Prudent Man Advisors LLC Decreases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Prudent Man Advisors LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,001 shares of the healthcare conglomerate’s stock after selling 71 shares during the period. Prudent Man Advisors LLC’s holdings in UnitedHealth Group were worth $1,020,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Outfitter Financial LLC purchased a new position in UnitedHealth Group in the 4th quarter worth $25,000. Advocacy Wealth Management Services LLC grew its position in UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the period. Cascade Investment Advisors Inc. grew its position in UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares during the period. Tortoise Investment Management LLC grew its position in UnitedHealth Group by 54.8% during the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 23 shares during the period. Finally, Leverty Financial Group LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $34,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Insider Buying and Selling

In related news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares in the company, valued at $581,936,400. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the sale, the director now directly owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO John F. Rex sold 13,183 shares of the business’s stock in a transaction on Friday, July 29th. The shares were sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the completion of the sale, the chief financial officer now directly owns 141,508 shares of the company’s stock, valued at $76,630,827.24. The disclosure for this sale can be found here. Over the last quarter, insiders sold 130,144 shares of company stock worth $69,269,555. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

UNH stock opened at $535.06 on Friday. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 0.77. The firm’s 50 day moving average price is $506.46 and its 200-day moving average price is $499.44. The firm has a market cap of $500.48 billion, a PE ratio of 27.94, a PEG ratio of 1.65 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter last year, the firm earned $4.70 EPS. The firm’s revenue for the quarter was up 12.6% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.86 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were paid a $1.65 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date was Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.23%. UnitedHealth Group’s payout ratio is 34.46%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on UNH. SVB Leerink raised their target price on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Morgan Stanley raised their target price on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price on the stock. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Cowen raised their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Finally, Oppenheimer raised their price target on shares of UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $582.50.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.